Hair loss (alopecia) is listed as a common side effect with atezolizumab (Tecentriq) when used with certain other cancer treatments. Hair loss was not reported as a side effect when used as a single agent for urothelial (bladder) cancer treatment (but Tecentriq is no longer FDA-approved to be used in bladder cancer).